Both in Pharmaceuticals
Kura Oncology vs MoonLake Immunotherapeutics
Over the past year KURA returned +20.5% and MLTX returned +83.3%; their daily moves had a correlation of 0.24.
KURA +20.5% MLTX +83.3%Growth of $1, one year, split-adjusted
| Metric | KURA | MLTX |
|---|---|---|
| Price | $10.81 | $11.45 |
| Market cap | $961.2M | $974.5M |
| Today | +1.84% | −0.95% |
| 1 month | −14.7% | −23.6% |
| 6 months | +39.8% | −32.4% |
| Year to date | +4.0% | −13.1% |
| 1 year | +19.4% | −81.5% |
| Revenue growth (YoY) | +36.5% | — |
| Gross margin | 98.8% | — |
| Net margin | −327.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 12.4× | — |
| Net cash | $509.2M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 52.2% |
| Short % of float | 19.0% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).